ATE472553T1 - Methansulfonatsalze von abirateron-3-estern und wiederherstellung von salzen von abirateron-3- estern durch auflösung in methyl-tert-butyl-ether - Google Patents

Methansulfonatsalze von abirateron-3-estern und wiederherstellung von salzen von abirateron-3- estern durch auflösung in methyl-tert-butyl-ether

Info

Publication number
ATE472553T1
ATE472553T1 AT05775781T AT05775781T ATE472553T1 AT E472553 T1 ATE472553 T1 AT E472553T1 AT 05775781 T AT05775781 T AT 05775781T AT 05775781 T AT05775781 T AT 05775781T AT E472553 T1 ATE472553 T1 AT E472553T1
Authority
AT
Austria
Prior art keywords
esters
salts
butyl ether
tert
methyl
Prior art date
Application number
AT05775781T
Other languages
English (en)
Inventor
Neil John Hunt
Original Assignee
Btg Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Int Ltd filed Critical Btg Int Ltd
Application granted granted Critical
Publication of ATE472553T1 publication Critical patent/ATE472553T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT05775781T 2004-08-24 2005-08-23 Methansulfonatsalze von abirateron-3-estern und wiederherstellung von salzen von abirateron-3- estern durch auflösung in methyl-tert-butyl-ether ATE472553T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60355904P 2004-08-24 2004-08-24
GBGB0418900.7A GB0418900D0 (en) 2004-08-24 2004-08-24 Novel salt forms
PCT/GB2005/003282 WO2006021776A1 (en) 2004-08-24 2005-08-23 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether

Publications (1)

Publication Number Publication Date
ATE472553T1 true ATE472553T1 (de) 2010-07-15

Family

ID=33104570

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05775781T ATE472553T1 (de) 2004-08-24 2005-08-23 Methansulfonatsalze von abirateron-3-estern und wiederherstellung von salzen von abirateron-3- estern durch auflösung in methyl-tert-butyl-ether

Country Status (21)

Country Link
US (5) US7700766B2 (de)
EP (1) EP1789432B1 (de)
JP (1) JP5069561B2 (de)
KR (2) KR101245727B1 (de)
CN (2) CN101044155B (de)
AT (1) ATE472553T1 (de)
AU (1) AU2005276298C1 (de)
BR (1) BRPI0514543A (de)
CA (1) CA2576922C (de)
CY (1) CY1110800T1 (de)
DE (1) DE602005022083D1 (de)
DK (1) DK1789432T3 (de)
ES (1) ES2345345T3 (de)
GB (1) GB0418900D0 (de)
MX (1) MX2007002032A (de)
NZ (1) NZ553085A (de)
PL (1) PL1789432T3 (de)
PT (1) PT1789432E (de)
SI (1) SI1789432T1 (de)
WO (1) WO2006021776A1 (de)
ZA (1) ZA200701533B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569275B2 (en) 2002-08-28 2013-10-29 Harbor Therapeutics, Inc. Steroids having 7-oxgen and 17-heteroaryl substitution
GB0418900D0 (en) * 2004-08-24 2004-09-29 Btg Int Ltd Novel salt forms
US8236946B2 (en) * 2004-08-24 2012-08-07 Btg International Limited Process for the preparation of 17-0-vinyl-triflates as intermediates
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
HRP20130961T1 (hr) * 2006-08-25 2013-11-22 Janssen Oncology, Inc. Kombinacije za tretman raka
UY32730A (es) 2009-06-26 2011-01-31 Novartis Ag Inhibidores de cyp17
EP2627648A1 (de) 2010-09-16 2013-08-21 Novartis AG 17a-HYDROXYLASE-C17, 20-LYASE-INHIBITOREN
CN102558274B (zh) * 2010-12-08 2014-10-15 深圳万乐药业有限公司 一种适合工业化生产醋酸阿比特龙的合成方法
CN102030798B (zh) * 2010-12-17 2012-10-17 深圳万乐药业有限公司 一种醋酸阿比特龙的纯化方法
MX359399B (es) 2011-04-28 2018-09-27 Novartis Ag Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
WO2013053691A1 (en) 2011-10-10 2013-04-18 Zach System Process for preparing 17-substituted steroids
CN103172690B (zh) * 2011-12-23 2016-08-24 重庆医药工业研究院有限责任公司 醋酸阿比特龙及其中间体的制备方法
EP2607371A1 (de) 2011-12-23 2013-06-26 Crystal Pharma, S.A.U. Verfahren zur Herstellung von Abirateron und verwandten Verbindungen
CN105461777B (zh) * 2012-01-04 2017-07-18 连云港润众制药有限公司 一种醋酸阿比特龙的纯化方法
CN103254265B (zh) 2012-02-21 2016-07-13 上海希迈医药科技有限公司 醋酸阿比特龙三氟乙酸盐及其制备方法和应用
CN103360458B (zh) * 2012-03-26 2015-05-20 信泰制药（苏州）有限公司 一种阿比特龙的合成方法
CN102731605B (zh) * 2012-06-19 2016-04-13 鲁南制药集团股份有限公司 一种醋酸阿比特龙的纯化方法
CN103665084A (zh) * 2012-09-04 2014-03-26 重庆安格龙翔医药科技有限公司 一种制备醋酸阿比特龙的方法
CN102816200B (zh) * 2012-09-05 2015-04-15 中山大学 一种醋酸阿比特龙的制备方法
CN102816201A (zh) * 2012-09-25 2012-12-12 成都伊诺达博医药科技有限公司 一种阿比特龙的纯化方法
WO2014058785A1 (en) 2012-10-10 2014-04-17 Novartis Ag Combination therapy
ITMI20121788A1 (it) 2012-10-22 2014-04-23 Olon Spa Procedimento per la purificazione di abiraterone acetato
EP2917226A1 (de) 2012-11-09 2015-09-16 Synthon BV Verfahren zur herstellung des 17-triflat-zwischenprodukts von abirateron-3-acetat
CA2890589A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making abiraterone-3-acetate
TWI570131B (zh) * 2012-11-13 2017-02-11 賽克系統公司 製備１７－經取代類固醇之方法
WO2014075978A1 (en) 2012-11-16 2014-05-22 Synthon B.V. Process for the production of abiraterone-3-acetate involving an enol trliflation reaction in the presence of an alkoxy-pyridine compound
CN103059091B (zh) * 2012-11-22 2017-04-19 常州靶点医药科技有限公司 一种避免重金属残留的醋酸阿比特龙的制备方法
US9962452B2 (en) 2013-02-04 2018-05-08 Zhuhai Beihai Biotech Co., Ltd. Soluble complexes of drug analogs and albumin
EP2792682B1 (de) * 2013-04-19 2016-11-09 Zach System Verfahren zur Herstellung einer festen Form von Abirateron-Azetat
CN103242410B (zh) * 2013-05-09 2015-08-26 苏州明锐医药科技有限公司 醋酸阿比特龙的制备方法
IN2013MU02133A (de) * 2013-06-24 2015-06-05 Sun Pharmaceutical Ind Ltd
JP6474799B2 (ja) * 2013-06-28 2019-02-27 サイノファーム タイワン，リミティド アビラテロン及びその中間体の調製方法
CZ306623B6 (cs) * 2013-07-04 2017-04-05 Zentiva, K.S. Soli abirateronu acetátu
EP3080141A1 (de) 2013-12-12 2016-10-19 Basf Se Feste form von abirateronacetat
ES2741505T3 (es) 2014-01-28 2020-02-11 Olon Spa Procedimiento para la preparación de acetato de abiraterona y sus productos intermedios
CN103965282B (zh) 2014-04-21 2016-01-20 武汉百科药物开发有限公司 一种醋酸阿比特龙的制备方法
US9315541B2 (en) * 2014-05-20 2016-04-19 Olon S.P.A. Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives
CN105294806A (zh) * 2014-06-13 2016-02-03 江苏希迪制药有限公司 一种制备醋酸阿比特龙中间体的方法
US9937259B2 (en) 2014-06-27 2018-04-10 Zhuhai Beihai Biotech Co., Ltd. Abiraterone derivatives and non-covalent complexes with albumin
US10201617B2 (en) 2014-10-24 2019-02-12 Zhuhai Beihai Biotech Co., Ltd. 3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
CN104447934B (zh) * 2014-12-08 2017-03-15 深圳科兴生物工程有限公司 一种醋酸阿比特龙的纯化方法
WO2016162229A1 (en) 2015-04-10 2016-10-13 Capsugel Belgium N.V. Abiraterone acetate lipid formulations
MX2019001224A (es) 2016-07-29 2019-06-03 Janssen Pharmaceutica Nv Metodos para tratar el cancer de prostata.
WO2018071544A1 (en) 2016-10-11 2018-04-19 Zhuhai Beihai Biotech Co., Ltd. Abiraterone derivative and formulations thereof
CN108586561B (zh) * 2018-04-03 2020-08-04 科兴生物制药股份有限公司 一种制备醋酸阿比特龙的方法
CN114026106B (zh) 2019-03-06 2025-01-21 普洛拉治疗公司 阿比特龙前药
CN112812147A (zh) * 2019-11-15 2021-05-18 江苏佳尔科药业集团股份有限公司 一种醋酸阿比特龙的合成方法及其中间体
WO2022174134A1 (en) 2021-02-15 2022-08-18 Propella Therapeutics, Inc. Abiraterone prodrugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ287434B6 (en) * 1992-03-31 2000-11-15 British Tech Group Use of steroids, substituted in position 17, steroids functioning as carcinostatics and pharmaceutical preparation containing thereof
US5604213A (en) * 1992-03-31 1997-02-18 British Technology Group Limited 17-substituted steroids useful in cancer treatment
DK0721461T3 (da) 1993-09-30 1999-09-20 Btg Int Ltd Syntese af 17-(3-pyridyl)-steroider
GB0418900D0 (en) * 2004-08-24 2004-09-29 Btg Int Ltd Novel salt forms

Also Published As

Publication number Publication date
US8338588B2 (en) 2012-12-25
ES2345345T3 (es) 2010-09-21
US7700766B2 (en) 2010-04-20
US20100152437A1 (en) 2010-06-17
JP5069561B2 (ja) 2012-11-07
SI1789432T1 (sl) 2010-10-29
KR20070049171A (ko) 2007-05-10
CN102863498A (zh) 2013-01-09
WO2006021776A1 (en) 2006-03-02
CA2576922A1 (en) 2006-03-02
KR101245727B1 (ko) 2013-03-25
US20130090468A1 (en) 2013-04-11
DK1789432T3 (da) 2010-08-16
US20070249836A1 (en) 2007-10-25
AU2005276298B2 (en) 2011-06-23
US8076474B2 (en) 2011-12-13
PL1789432T3 (pl) 2010-11-30
KR101358661B1 (ko) 2014-02-07
CN102863498B (zh) 2015-04-08
AU2005276298C1 (en) 2012-02-02
HK1103091A1 (en) 2007-12-14
EP1789432A1 (de) 2007-05-30
US20150329585A1 (en) 2015-11-19
EP1789432B1 (de) 2010-06-30
NZ553085A (en) 2010-08-27
CA2576922C (en) 2013-05-07
ZA200701533B (en) 2008-08-27
HK1180694A1 (en) 2013-10-25
PT1789432E (pt) 2010-08-09
GB0418900D0 (en) 2004-09-29
JP2008510780A (ja) 2008-04-10
AU2005276298A1 (en) 2006-03-02
KR20120135931A (ko) 2012-12-17
CN101044155B (zh) 2012-10-10
CY1110800T1 (el) 2015-06-10
US20120053340A1 (en) 2012-03-01
BRPI0514543A (pt) 2008-06-17
CN101044155A (zh) 2007-09-26
MX2007002032A (es) 2007-10-11
DE602005022083D1 (de) 2010-08-12

Similar Documents

Publication Publication Date Title
ATE472553T1 (de) Methansulfonatsalze von abirateron-3-estern und wiederherstellung von salzen von abirateron-3- estern durch auflösung in methyl-tert-butyl-ether
ES2531190T3 (es) Método para producir un compuesto de 4-oxoquinolina
EA200900676A1 (ru) Ингибиторы вируса гепатита с
DK2020996T3 (da) Fremgangsmåder og sammensætninger til behandling af hæmatologiske sygdomme
NO20091871L (no) Hepatitt C virus inhibitorer
MX2009011579A (es) Pirimidinonas como moduladores de caseina cinasa ii (ck2).
DK2057126T3 (da) Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater
EA200500239A1 (ru) Новый способ синтеза (1s)-4-,5-диметокси-1-(метиламинометил)-бензоциклобутана и его солей присоединения и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
DK1781683T3 (da) Fremgangsmåde til fremstilling af 17-vinyl-triflater som halvfabrikata
NO20070122L (no) Quinazolinonderivater anvendelige som vanilloidantagonister
WO2008008776A3 (en) Hepatitis c virus inhibitors
EA200970805A1 (ru) Ингибиторы серинпротеаз для лечения hcv инфекций
NZ594671A (en) Compositions and methods for inhibiting the agglomeration of hydrates in a process
AR062797A1 (es) Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas.
EA201270275A1 (ru) Кристаллическое соединение пиридазина
EA201171329A1 (ru) Твердый препарат
EP2196460A4 (de) Sulfonsäuresalzverbindung eines 4-carbamoyl-5-hydroxyimidazolderivats
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
UY29857A1 (es) Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica.
DK1885187T3 (da) Fremgangsmåde til behandling af lægemiddelresistent cancer
DK1735309T3 (da) Forbedret fremgangsmåde til fremstilling af N-([1,2,4]triazolopyrimidin-2-yl)arylsulfonamider
EA201170273A1 (ru) Твердая фармацевтическая композиция
AR073871A1 (es) Intermediario de fulvestran
AR079299A1 (es) Mejora de los procesos para la preparacion de granulos solubles de las sales de los acidos carboxilicos que contienen piridina